These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28478369)

  • 1. Designer probiotics for the prevention and treatment of human diseases.
    Chua KJ; Kwok WC; Aggarwal N; Sun T; Chang MW
    Curr Opin Chem Biol; 2017 Oct; 40():8-16. PubMed ID: 28478369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Bacteria for Therapeutics.
    Vo P; Lee HM; Na D
    J Microbiol Biotechnol; 2019 Jun; 29(6):845-855. PubMed ID: 31216840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics of Diverse Origin and Their Therapeutic Applications: A Review.
    Yadav M; Mandeep ; Shukla P
    J Am Coll Nutr; 2020 Jul; 39(5):469-479. PubMed ID: 31765283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction of the role of probiotics in human infections and autoimmune diseases.
    Sales-Campos H; Soares SC; Oliveira CJF
    Crit Rev Microbiol; 2019 Aug; 45(4):413-432. PubMed ID: 31157574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering probiotics as living diagnostics and therapeutics for improving human health.
    Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
    Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Might patients with immune-related diseases benefit from probiotics?
    Homayouni Rad A; Torab R; Ghalibaf M; Norouzi S; Mehrabany EV
    Nutrition; 2013 Mar; 29(3):583-6. PubMed ID: 23398922
    [No Abstract]   [Full Text] [Related]  

  • 7. Living Therapeutics: The Next Frontier of Precision Medicine.
    Kelly VW; Liang BK; Sirk SJ
    ACS Synth Biol; 2020 Dec; 9(12):3184-3201. PubMed ID: 33205966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy.
    Alvarez-Olmos MI; Oberhelman RA
    Clin Infect Dis; 2001 Jun; 32(11):1567-76. PubMed ID: 11340528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of vector-borne infectious diseases by human immunity against α-Gal.
    Cabezas Cruz A; Valdés JJ; de la Fuente J
    Expert Rev Vaccines; 2016 Aug; 15(8):953-5. PubMed ID: 27100121
    [No Abstract]   [Full Text] [Related]  

  • 10. Holobionts: emerging strategy for interventions against infectious diseases, metabolic disorders & cancer.
    Singh Y; Hasnain SE
    Indian J Med Res; 2014 Jul; 140(1):11-4. PubMed ID: 25222772
    [No Abstract]   [Full Text] [Related]  

  • 11. Probiotics in childhood: allergic illness and respiratory infections.
    del Giudice MM; Leonardi S; Ciprandi G; Galdo F; Gubitosi A; La Rosa M; Salpietro C; Marseglia G; Perrone L
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S69-72. PubMed ID: 22955363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic biology approaches to engineer T cells.
    Wu CY; Rupp LJ; Roybal KT; Lim WA
    Curr Opin Immunol; 2015 Aug; 35():123-30. PubMed ID: 26218616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
    Bober JR; Beisel CL; Nair NU
    Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on acupuncture and moxibustion immunity and its regulation].
    Chen HP
    Zhen Ci Yan Jiu; 1988; 13(3):167-78. PubMed ID: 3150303
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering Diagnostic and Therapeutic Gut Bacteria.
    Landry BP; Tabor JJ
    Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered bacteria as therapeutic agents.
    Piñero-Lambea C; Ruano-Gallego D; Fernández LÁ
    Curr Opin Biotechnol; 2015 Dec; 35():94-102. PubMed ID: 26070111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferons--Part 1.
    Freeman PR
    Am Pharm; 1994 May; NS34(5):24-6. PubMed ID: 7518644
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospects of using marine actinobacteria as probiotics in aquaculture.
    Das S; Ward LR; Burke C
    Appl Microbiol Biotechnol; 2008 Dec; 81(3):419-29. PubMed ID: 18841358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity.
    Lavelle EC; McLachlan JB
    Curr Opin Pharmacol; 2018 Aug; 41():vii-ix. PubMed ID: 30139514
    [No Abstract]   [Full Text] [Related]  

  • 20. [The procedures for using immunological study methods in different diseases].
    Nikulin BA
    Voen Med Zh; 1994 Jan; (1):26-31, 80. PubMed ID: 8178499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.